Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses MED in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MED in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Daniel Chard | $1,000,000 | $0 | $4,567,664 | $0 | $0 | $0 | $16,886 | $5,584,551 |
| Chairman & Chief Executive Officer | ||||||||
| Anthony Tyree | 415,873 | 0 | 162,194 | 0 | 145,556 | 0 | 761,097 | 1,484,720 |
| Former Chief Business Operations Officer | ||||||||
| James Maloney | 527,085 | 0 | 700,427 | 0 | 184,480 | 0 | 16,403 | 1,428,396 |
| Chief Financial Officer | ||||||||
| Nicholas Johnson | 440,352 | 0 | 585,163 | 0 | 154,123 | 0 | 15,980 | 1,195,619 |
| Chief Field Operations Officer | ||||||||
| Jason Groves | 427,781 | 0 | 568,465 | 0 | 149,723 | 0 | 14,483 | 1,160,452 |
| Chief Legal Officer & Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Daniel Chard | $5,584,551 | — | — | — |
| Anthony Tyree | 1,484,720 | — | — | — |
| James Maloney | 1,428,396 | — | — | — |
| Nicholas Johnson | 1,195,619 | — | — | — |
| Jason Groves | 1,160,452 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jason Groves | PSU | 2025-03-25 | — | — | — | — | $271,781 |
| Jason Groves | PSU | 2025-03-25 | 4,902 | 19,609 | — | 35,949 | 296,684 |
| Daniel Chard | PSU | 2025-03-25 | — | — | — | — | 1,731,849 |
| Daniel Chard | PSU | 2025-03-25 | 46,858 | 187,430 | — | 343,615 | 2,835,816 |
| Nicholas Johnson | PSU | 2025-03-25 | — | — | — | — | 279,764 |
| Nicholas Johnson | PSU | 2025-03-25 | 5,046 | 20,185 | — | 37,005 | 305,399 |
| James Maloney | PSU | 2025-03-25 | 6,040 | 24,161 | — | 44,294 | 365,556 |
| James Maloney | PSU | 2025-03-25 | — | — | — | — | 334,871 |
| Anthony Tyree | PSU | 2025-03-25 | 1,589 | 6,354 | — | 11,649 | 96,141 |
| Anthony Tyree | PSU | 2025-03-25 | — | — | — | — | 66,053 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jason Groves | $0 | $568,465 | $0 | 100.0% |
| Daniel Chard | 0 | 4,567,665 | 0 | 100.0% |
| Nicholas Johnson | 0 | 585,163 | 0 | 100.0% |
| James Maloney | 0 | 700,427 | 0 | 100.0% |
| Anthony Tyree | 0 | 162,194 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Daniel Chard | PSU | 187,430 | — | $2,001,752 |
| Daniel Chard | RSU | 124,953 | — | 1,334,498 |
| Daniel Chard | PSU | 67,631 | — | 722,299 |
| Daniel Chard | RSU | 30,058 | — | 321,019 |
| James Maloney | PSU | 24,161 | — | 258,039 |
| James Maloney | RSU | 24,161 | — | 258,039 |
| Nicholas Johnson | PSU | 20,185 | — | 215,576 |
| Nicholas Johnson | RSU | 20,185 | — | 215,576 |
| Jason Groves | PSU | 19,609 | — | 209,424 |
| Jason Groves | RSU | 19,609 | — | 209,424 |
| James Maloney | PSU | 8,718 | — | 93,108 |
| Nicholas Johnson | PSU | 7,284 | — | 77,793 |
| Jason Groves | PSU | 7,076 | — | 75,572 |
| James Maloney | RSU | 5,812 | — | 62,072 |
| Daniel Chard | RSU | 5,603 | — | 59,840 |
| Nicholas Johnson | RSU | 4,856 | — | 51,862 |
| Jason Groves | RSU | 4,718 | — | 50,388 |
| James Maloney | RSU | 1,525 | — | 16,287 |
| Nicholas Johnson | RSU | 1,308 | — | 13,969 |
| Jason Groves | RSU | 1,238 | — | 13,222 |
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-19 | 3,996,046 | 637,173 | 15,874 | 86.25% | Passed |
| 2025 | 2025-06-18 | 3,585,469 | 2,477,849 | 128,492 | 59.13% | Passed |
| 2024 | 2024-06-19 | 6,875,928 | 248,088 | 20,611 | 96.52% | Passed |
| 2023 | 2023-06-14 | 7,495,497 | 372,673 | 87,201 | 95.26% | Passed |
| 2022 | 2022-06-15 | 8,615,230 | 304,225 | 153,696 | 96.59% | Passed |
| 2021 | 2021-06-02 | 8,651,595 | 244,600 | 20,001 | 97.25% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-19 | 86.25%a |
| 2025 | 2025-06-18 | 59.13%b |
| 2024 | 2024-06-19 | 96.52%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 57 : 1 |
|---|---|
| CEO total compensation | — |
| Median employee compensation | $97,437 |
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | Non-Employee Directors: 5x amount of annual cash retainer |
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Medifast names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Medifast.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewell Personal Care Company | 2025 | Rod Little | $1,100,000 | $7,576,100 | $0 | $907,500 | $9,754,366 |
| 2 | Olaplex Holdings, Inc. | 2025 | Amanda Baldwin | 1,000,000 | 5,000,000 | 0 | 515,000 | 6,541,537 |
| 3 | Medifast | 2025 | Daniel Chard | 1,000,000 | 4,567,664 | 0 | 0 | 5,584,551 |
| 4 | B&G Foods, Inc. | 2025 | Kenneth Keller | 1,224,258 | 2,625,864 | 0 | 710,437 | 4,589,619 |
| 5 | FLOWERS.COM, Inc. | 2025 | Adolfo Villagomez | 107,692 | 1,500,002 | 1,500,003 | 0 | 3,107,697 |
| — | Herbalife Ltd. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Medifast | not disclosed | not disclosed | not disclosed | not disclosed |
| B&G Foods, Inc. | not disclosed | PSU 50 · Restricted Stock 50 | not disclosed | Meridian Compensation Partners |
| Edgewell Personal Care Company | 66% | not disclosed | No | Meridian |
| FLOWERS.COM, Inc. | not disclosed | RSU 50 · PSU 50 | not disclosed | Pearl Meyer |
| Herbalife Ltd. | not disclosed | not disclosed | not disclosed | not disclosed |
| Olaplex Holdings, Inc. | 103% | RSU 100 | not disclosed | Aon |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Daniel Chard | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation”. As printed: 5,584,551. Filing ↗machine: r2 · c48 · span 1222305–1222314 |
| 2 | Section 01, Anthony Tyree | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation”. As printed: 1,484,720. Filing ↗machine: r11 · c48 · span 1240632–1240641 |
| 3 | Section 01, James Maloney | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation”. As printed: 1,428,396. Filing ↗machine: r5 · c48 · span 1228443–1228452 |
| 4 | Section 01, Nicholas Johnson | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation”. As printed: 1,195,619. Filing ↗machine: r8 · c48 · span 1234255–1234264 |
| 5 | Section 01, Jason Groves | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation”. As printed: 1,160,452. Filing ↗machine: r14 · c48 · span 1246455–1246464 |
| 6 | Section 03, Jason Groves PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1310137–1310144 |
| 7 | Section 03, Jason Groves PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1308231–1308238 |
| 8 | Section 03, Daniel Chard PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1285451–1285460 |
| 9 | Section 03, Daniel Chard PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1283542–1283551 |
| 10 | Section 03, Nicholas Johnson PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1297600–1297607 |
| 11 | Section 03, Nicholas Johnson PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1295694–1295701 |
| 12 | Section 03, James Maloney PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1289619–1289626 |
| 13 | Section 03, James Maloney PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1291525–1291532 |
| 14 | Section 03, Anthony Tyree PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1301941–1301947 |
| 15 | Section 03, Anthony Tyree PSU | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1303845–1303851 |
| 16 | Section 07, pay ratio | DEF 14A | 2026-04-06 | 0001628280-26-023890 | Section “CEO Pay Ratio”. As printed: 57 : 1. Filing ↗ |
| 17 | Section 06, 2026 vote | Form 8-K | 2026-05-26 | 0001628280-26-038109 | Item 5.07 · say-on-pay result. As reported: 86.25% (votes for as printed: 3,996,046). Filing ↗ |
| 18 | Section 06, 2025 vote | Form 8-K | 2025-06-20 | 0001628280-25-032457 | Item 5.07 · say-on-pay result. As reported: 59.13% (votes for as printed: 3,585,469). Filing ↗ |
| 19 | Section 06, 2024 vote | Form 8-K | 2024-06-21 | 0001628280-24-029369 | Item 5.07 · say-on-pay result. As reported: 96.52% (votes for as printed: 6,875,928). Filing ↗ |
| 20 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 21 | Edgewell Personal Care Company, Section 10b CEO total | DEF 14A | 2025-12-22 | 0001104659-25-123567 | CEO total compensation as printed in Edgewell Personal Care Company's own proxy. As printed: 9,754,366. Filing ↗machine: t89 · r1 · c51 · span 1153139–1153148 |
| 22 | Olaplex Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-05-29 | 0001868726-26-000044 | CEO total compensation as printed in Olaplex Holdings, Inc.'s own proxy. As printed: 6,541,537. Filing ↗machine: t27 · r3 · c8 · span 629363–629372 |
| 23 | Medifast (subject), Section 10b CEO total | DEF 14A | 2026-04-06 | 0001628280-26-023890 | CEO total compensation as printed in Medifast's own proxy. As printed: 5,584,551. Filing ↗machine: r2 · c48 · span 1222305–1222314 |
| 24 | B&G Foods, Inc., Section 10b CEO total | DEF 14A | 2026-04-03 | 0001104659-26-039621 | CEO total compensation as printed in B&G Foods, Inc.'s own proxy. As printed: 4,589,619. Filing ↗ |
| 25 | FLOWERS.COM, Inc., Section 10b CEO total | DEF 14A | 2025-10-23 | 0001084869-25-000025 | CEO total compensation as printed in FLOWERS.COM, Inc.'s own proxy. As printed: 3,107,697. Filing ↗machine: r3 · c39 · span 333486–333495 |
| 26 | Section 10a, B&G Foods, Inc. reciprocity | DEF 14A | — | 0001104659-26-039621 | B&G Foods, Inc.'s most recent proxy was read; its disclosed peer group does not include Medifast. Filing ↗ |
| 27 | Section 10a, Edgewell Personal Care Company reciprocity | DEF 14A | — | 0001104659-25-123567 | Edgewell Personal Care Company's most recent proxy was read; its disclosed peer group does not include Medifast. Filing ↗ |